Biological effect of PCBs, PCQs and PCDFs present in the oil causing Yusho and Yu-Cheng
Male Sprague-Dawley rats were daily given orally for 22 days a regimen consisting of polychlorinated biphenyls (PCBs), 1 mg/day; polychlorinated quaterphenyls (PCQs), 1 mg/day; polychlorinated dibenzofurans (PCDFs), 10 ..mu..g/day; or a mixture of PCBs, PCQs and PCDFs (Mix-1, 1 mg + 1 mg + 10 ..mu..g/day). Female cynomolgus monkeys were daily administered PCBs (5 mg), PCQs (5 mg) or a mixture (Mix-2) containing 5 mg PCBs + 20 ..mu..g PCDFs for 20 weeks. The PCB-treated rats and monkeys showed hepatic hypertrophy, immunosuppression and increased drug-metabolizing enzyme activities in hepatic microsomes, but were devoid of the dermal symptoms characteristic of Yusho. PCQs caused an increase in drug-metabolizing enzyme activities in hepatic microsomes and immunosuppression in monkeys, but these effects were much smaller than those found with PCBs treatment. On the other hand, treatment with PCDF or Mix-1 or Mix-2 caused hypertrophy of the liver, immunosuppression, increase in drug-metabolizing enzyme activities of hepatic microsome to much greater extent than observed with PCBs. In addition PCDFs and the mixtures containing PCDFs caused weight loss and thymic atrophy. PCDFs and Mix-2-treated monkeys showed the dermal symptoms that are characteristic of Yusho patients but were not observed in monkeys treated with PCBs and PCQs alone. These results suggest that PCDFs are the primary causative agent of Yusho.
- Research Organization:
- National Osaka Hospital, Japan
- OSTI ID:
- 5414652
- Journal Information:
- Environ. Health Perspect.; (United States), Vol. 59
- Country of Publication:
- United States
- Language:
- English
Similar Records
PCBs, PCQs and PCDFs in blood of Yusho and Yu-Cheng patients
PCBs, PCQs and PCDFs in tissues of Yusho and Yu-Cheng patients
Related Subjects
BENZOFURANS
BIOLOGICAL EFFECTS
ORAL ADMINISTRATION
CHLORINATED AROMATIC HYDROCARBONS
LIVER
ENZYME ACTIVITY
HYPERTROPHY
QUATERPHENYLS
THYMUS
ATROPHY
ETIOLOGY
IMMUNOSUPPRESSION
JAPAN
MONKEYS
PATIENTS
RATS
SKIN
TAIWAN
VEGETABLE OILS
WEIGHT
ANIMALS
AROMATICS
ASIA
BODY
DIGESTIVE SYSTEM
FURANS
GLANDS
HALOGENATED AROMATIC HYDROCARBONS
HETEROCYCLIC COMPOUNDS
HYDROCARBONS
ISLANDS
LYMPHATIC SYSTEM
MAMMALS
OILS
ORGANIC CHLORINE COMPOUNDS
ORGANIC COMPOUNDS
ORGANIC HALOGEN COMPOUNDS
ORGANIC OXYGEN COMPOUNDS
ORGANS
OTHER ORGANIC COMPOUNDS
PATHOLOGICAL CHANGES
PRIMATES
RODENTS
VERTEBRATES
560305* - Chemicals Metabolism & Toxicology- Vertebrates- (-1987)